ANADYS PHARMACEUTICALS INC
CIK 0001128495
Revenue (TTM)
—
Q3 Oct 2011
Net Income (TTM)
−$24.98M
Q3 Oct 2011
EPS Diluted (TTM)
—
Q3 Oct 2011
Gross Margin
—
Q3 Oct 2011
Operating Margin
—
Q3 Oct 2011
Net Margin
—
Q3 Oct 2011
Free Cash Flow (TTM)
—
Q3 Oct 2011
Cash
$1.08M
Q3 Oct 2011
Total Debt
—
Q3 Oct 2011
Shares Outstanding
57.44M sh
Q3 Oct 2011